High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study.

By G. Walldius, I. Jungner, I. Holme, A. Aastveit, W. Kolar, E. Steiner. The Lancet, 2001

1,349 citations recorded by the source corpus.

Subfields: Hematology, Pathology and Forensic Medicine

View Paper: https://www.semanticscholar.org/paper/47b4b8b77fa204ec423383cad2a30031f3a09f5b

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Hematology

In Pathology and Forensic Medicine

G. Moneta

Citations in the corpus

Non-HDL cholesterol, apolipoproteins A-I and B100, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women. (2005, background): “In this regard, there was virtually no use of statin therapy at the time of enrollment into the WHS and overall usage rates remained very low at all points of follow-up reflecting the low-risk nature of this cohort.19 However, in the Air Force Texas Coronary Atherosclerosis Prevention Study (AFCAPS/”
Clinical utility of different lipid measures for prediction of coronary heart disease in men and women. (2007, background): “Also, several prior studies have compared the lipid measures by including several of them in the same multivariable models or by use of stepwise selection from such models.(6,9,11,12) This statistical approach is challenged by the high degree of correlation among the lipid measures and may be prone ”
Major Lipids, Apolipoproteins, and Risk of Vascular Disease (2010, methodology): “The AMORIS study provided data for the ERFC, but it could not be incorporated into the current analyses because AMORIS did not measure baseline levels of HDL-C, blood pressure, smoking, body mass index, or diabetes.(14) All but 1 study used enzymatic methods to assay triglyceride, and all but 2 stud”
Major Lipids, Apolipoproteins, and Risk of Vascular Disease (2009, neutral): “The AMORIS study provided data for the ERFC, but it could not be incorporated into the current analyses because AMORIS did not measure baseline levels of HDL-C, blood pressure, smoking, body mass index, or diabetes.(14) All but 1 study used enzymatic methods to assay triglyceride, and all but 2 stud”